14-24308385-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_174913.3(NOP9):​c.*3290C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.94 in 194,966 control chromosomes in the GnomAD database, including 86,329 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.94 ( 66739 hom., cov: 29)
Exomes 𝑓: 0.96 ( 19590 hom. )

Consequence

NOP9
NM_174913.3 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0760

Publications

3 publications found
Variant links:
Genes affected
NOP9 (HGNC:19826): (NOP9 nucleolar protein) Enables RNA binding activity. Predicted to be involved in ribosome biogenesis. Predicted to be part of 90S preribosome and preribosome, small subunit precursor. Predicted to be active in nucleolus. [provided by Alliance of Genome Resources, Apr 2022]
CIDEB (HGNC:1977): (cell death inducing DFFA like effector b) Enables identical protein binding activity. Involved in activation of cysteine-type endopeptidase activity; positive regulation of cell death; and positive regulation of release of cytochrome c from mitochondria. Acts upstream of or within apoptotic process. Located in cytosol and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
LTB4R2 (HGNC:19260): (leukotriene B4 receptor 2) Predicted to enable G protein-coupled peptide receptor activity and leukotriene B4 receptor activity. Predicted to be involved in inflammatory response and neuropeptide signaling pathway. Predicted to act upstream of or within keratinocyte migration and signal transduction. Located in nucleoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.958 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_174913.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NOP9
NM_174913.3
MANE Select
c.*3290C>G
3_prime_UTR
Exon 10 of 10NP_777573.1Q86U38-1
NOP9
NM_001286367.2
c.*3427C>G
3_prime_UTR
Exon 10 of 10NP_001273296.1Q86U38-2
CIDEB
NM_001318807.3
c.-63+94G>C
intron
N/ANP_001305736.1Q9UHD4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NOP9
ENST00000267425.8
TSL:1 MANE Select
c.*3290C>G
3_prime_UTR
Exon 10 of 10ENSP00000267425.3Q86U38-1
CIDEB
ENST00000258807.5
TSL:1
c.-63+94G>C
intron
N/AENSP00000258807.5Q9UHD4
CIDEB
ENST00000967605.1
c.-527G>C
5_prime_UTR
Exon 1 of 5ENSP00000637664.1

Frequencies

GnomAD3 genomes
AF:
0.936
AC:
142251
AN:
151930
Hom.:
66708
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.890
Gnomad AMI
AF:
0.980
Gnomad AMR
AF:
0.929
Gnomad ASJ
AF:
0.963
Gnomad EAS
AF:
0.850
Gnomad SAS
AF:
0.948
Gnomad FIN
AF:
0.975
Gnomad MID
AF:
0.962
Gnomad NFE
AF:
0.964
Gnomad OTH
AF:
0.942
GnomAD4 exome
AF:
0.955
AC:
40987
AN:
42918
Hom.:
19590
Cov.:
0
AF XY:
0.955
AC XY:
21787
AN XY:
22820
show subpopulations
African (AFR)
AF:
0.905
AC:
1235
AN:
1364
American (AMR)
AF:
0.941
AC:
3360
AN:
3572
Ashkenazi Jewish (ASJ)
AF:
0.965
AC:
789
AN:
818
East Asian (EAS)
AF:
0.864
AC:
2420
AN:
2800
South Asian (SAS)
AF:
0.958
AC:
6389
AN:
6672
European-Finnish (FIN)
AF:
0.974
AC:
1126
AN:
1156
Middle Eastern (MID)
AF:
0.963
AC:
104
AN:
108
European-Non Finnish (NFE)
AF:
0.969
AC:
23764
AN:
24536
Other (OTH)
AF:
0.951
AC:
1800
AN:
1892
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
85
169
254
338
423
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
236
472
708
944
1180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.936
AC:
142337
AN:
152048
Hom.:
66739
Cov.:
29
AF XY:
0.935
AC XY:
69540
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.890
AC:
36848
AN:
41420
American (AMR)
AF:
0.929
AC:
14190
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.963
AC:
3340
AN:
3470
East Asian (EAS)
AF:
0.849
AC:
4376
AN:
5152
South Asian (SAS)
AF:
0.947
AC:
4564
AN:
4820
European-Finnish (FIN)
AF:
0.975
AC:
10331
AN:
10596
Middle Eastern (MID)
AF:
0.959
AC:
282
AN:
294
European-Non Finnish (NFE)
AF:
0.964
AC:
65521
AN:
67990
Other (OTH)
AF:
0.943
AC:
1991
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
448
897
1345
1794
2242
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.947
Hom.:
8478
Bravo
AF:
0.930
Asia WGS
AF:
0.901
AC:
3134
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
1.8
DANN
Benign
0.67
PhyloP100
0.076
PromoterAI
-0.00060
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2180197; hg19: chr14-24777591; API